| 产品编号 | CFN70256 | |
| CAS编号 | 1055329-49-1 | |
| 分子式 = 分子量 | C36H58O9 = 634.9 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Triterpenoids | |
| 植物来源 | The herbs of Sutherlandia frutescens | |
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| Sutherlandioside D | CFN70256 | 1055329-49-1 | 1mg | QQ客服:3004468087 |
| Sutherlandioside D | CFN70256 | 1055329-49-1 | 5mg | QQ客服:3004468087 |
| Sutherlandioside D | CFN70256 | 1055329-49-1 | 10mg | QQ客服:3004468087 |
| Sutherlandioside D | CFN70256 | 1055329-49-1 | 20mg | QQ客服:3004468087 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Sutherlandioside D may exert anti-cancer effect by targeting Gli/Hh signaling. |
| Targets: | Gli/Hh |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.5751 mL | 7.8753 mL | 15.7505 mL | 31.501 mL | 39.3763 mL |
| 5 mM | 0.315 mL | 1.5751 mL | 3.1501 mL | 6.3002 mL | 7.8753 mL |
| 10 mM | 0.1575 mL | 0.7875 mL | 1.5751 mL | 3.1501 mL | 3.9376 mL |
| 50 mM | 0.0315 mL | 0.1575 mL | 0.315 mL | 0.63 mL | 0.7875 mL |
| 100 mM | 0.0158 mL | 0.0788 mL | 0.1575 mL | 0.315 mL | 0.3938 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 1,2,3,19-四羟基-12-乌苏烯-28-酸; 1,2,3,19-Tetrahydroxy-12-ursen-28-oic acid | CFN99233 | 113558-03-5 | C30H48O6 = 504.7 | 5mg | QQ客服:3004468088 |
| 补骨脂乙素; Isobavachalcone | CFN98593 | 20784-50-3 | C20H20O4 = 324.37 | 20mg | QQ客服:3004468088 |
| 艾黄素; Artemetin | CFN98731 | 479-90-3 | C20H20O8 = 388.4 | 20mg | QQ客服:3004468088 |
| 8-氧代黄连碱; 8-氧黄连碱; 8-Oxycoptisine | CFN92158 | 19716-61-1 | C19H13NO5 = 335.3 | 20mg | QQ客服:3004468091 |